Skip to main content
Billions Co.,Ltd. logo

Billions Co.,Ltd. — Investor Relations & Filings

Ticker · 044480 ISIN · KR7044480002 KO Wholesale and retail trade
Open in API
Filings indexed 590 across all filing types
Latest filing 2020-03-26 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 044480

About Billions Co.,Ltd.

http://www.unidus.co.kr

Billions Co.,Ltd. is a company with diversified operations in the entertainment and manufacturing sectors. In the entertainment field, the company is involved in artist management and the production of dramas and movies. Concurrently, its manufacturing division produces and markets latex medical products, including prophylactics, surgical gloves, and finger cots. The company has previously operated under different names, including Blade Entertainment Co Ltd and Unidus Corporation, reflecting its distinct business segments.

Recent filings

Filing Released Lang Actions
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 95% confidence The document is a regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically functions as a '정정신고' (Correction Report) regarding the cancellation of previously granted stock options. In the context of Korean corporate filings (DART), this type of disclosure regarding stock option grants, cancellations, or changes is classified under general regulatory filings when it does not fit into specific categories like Director's Dealing or Remuneration. Since it is a formal regulatory update regarding equity-based compensation structure, it falls under the RNS (Regulatory Filings) category.
2020-03-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) and the Korea Exchange (KRX) when an executive or major shareholder changes their ownership stake in a listed company. This specific document details the resignation of an executive (Ahn Ju-hoon) and the resulting change in his shareholding status. This falls under the category of Director's Dealing (DIRS), which covers reports of share transactions or changes in ownership by company directors and executives.
2020-03-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is specifically used to report changes in share ownership by company insiders (directors/executives). In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers personal share transactions and changes in holdings by company directors and executives.
2020-03-26 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 98% confidence The document is a 'Major Matter Report' (주요사항보고서) from a Korean company (Kyungnam Bio Pharma) detailing a decision for a third-party capital increase (유상증자결정). This type of filing is a regulatory announcement regarding changes in capital structure and share issuance. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'Share Issue/Capital Change' (SHA) category.
2020-03-26 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed with the Korean regulatory authority (KRX). It provides the auditor's opinion (적정/Unqualified), key financial data (assets, liabilities, equity, profit/loss), and confirms the receipt of the audit report from the external auditor (대현회계법인). While it contains financial data, it is a regulatory filing announcing the completion and submission of the audit, rather than the full Annual Report (10-K) or a standalone audit report document. Therefore, it fits best as a Regulatory Filing (RNS) or a report publication announcement, but given the specific nature of the audit submission filing in the Korean market, RNS is the most appropriate classification. FY 2019
2020-03-18 Korean
주주총회집중일개최사유신고
Regulatory Filings Classification · 95% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) regarding the 'Reason for Holding a General Meeting on a Concentrated Date'. It explains why the company's Annual General Meeting (AGM) falls on a date designated as a 'concentrated date' by the KOSDAQ Association. Since this is a regulatory disclosure regarding meeting logistics rather than the meeting materials themselves (AGM-R) or a proxy statement (PSI), it falls under the general regulatory filing category.
2020-03-11 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.